Marking the 20th anniversary of the Montreal Cognitive Assessment (MoCA), the globally recognized screening tool for early cognitive impairment, the team behind its development has launched ...
NEW YORK, April 29, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF)'s Diagnostics Accelerator (DxA) today announced a significant investment that will support clinical validation ...
The gold standard pen-and-paper MoCA, developed in 1996 and clinically validated in 2005, demonstrated 90% sensitivity and 87% specificity for detecting MCI. The assessment includes questions designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results